Examkin

Question

Difficulty: MediumDiagnostic Testing Performance

A 68-year-old woman is evaluated in the emergency department for sudden-onset pleuritic chest pain, dyspnea, and hemoptysis. Her pulse is 115/min, and her respiratory rate is 24/min. Physical examination reveals unilateral right calf swelling and tenderness. Based on clinical scoring, her pretest probability for a pulmonary embolism is categorized as high. A junior resident suggests ordering a high-sensitivity D-dimer assay; if the result is negative, the resident plans to safely exclude the condition and discharge the patient, but if positive, proceed to computed tomography pulmonary angiography (CTPA). Which of the following statistical principles best explains why the resident's proposed diagnostic strategy is flawed?

  1. The negative predictive value of the initial assay is insufficient to safely exclude the diagnosis in a high-prevalence setting.Answer
  2. B
    The intrinsic sensitivity of the initial assay decreases significantly when applied to a patient cohort with a high pretest probability.
  3. C
    Using a highly sensitive screening test prior to a highly specific confirmatory test inevitably increases the overall false-positive rate.
  4. D
    The area under the receiver operating characteristic curve for the initial assay is minimized in populations with severe symptoms.
  5. E
    The positive likelihood ratio of the initial assay is inversely proportional to the patient's baseline clinical risk.

Answer

The resident's strategy is flawed because the negative predictive value of the initial assay is insufficient to safely exclude the diagnosis in a high-prevalence setting.
The correct principle is that the negative predictive value (NPV) of a test decreases as the pretest probability of the disease increases. The NPV is mathematically defined as NPV=True NegativesTrue Negatives+False Negatives\text{NPV} = \frac{\text{True Negatives}}{\text{True Negatives} + \text{False Negatives}} In a patient with a high pretest probability of pulmonary embolism (PE), the absolute number of false negatives increases relative to true negatives. Consequently, a negative D-dimer result in this patient does not reliably lower the post-test probability enough to safely exclude PE without further imaging. The standard of care mandates that patients with a high pretest probability bypass the D-dimer test and proceed directly to diagnostic imaging, such as CT pulmonary angiography.

Step-by-Step Solution

1
Identify the patient's pretest probability for the suspected disease.
The patient has a unequivocally high clinical pretest probability for a pulmonary embolism based on her symptoms (hemoptysis, dyspnea, pleuritic pain) and signs (tachycardia, unilateral calf swelling).
Establishing the baseline risk is required to appropriately select and interpret diagnostic tests.
2
Analyze the role of the proposed diagnostic test.
The D-dimer assay is highly sensitive but lacks specificity. It is typically utilized as a rule-out test in low- to intermediate-risk populations.
Tests must be deployed in patient populations where their predictive values yield actionable clinical conclusions.
3
Apply Bayes' theorem to predict test performance in this specific patient.
As the pretest probability of a disease increases, the Negative Predictive Value (NPV) decreases.
NPV is heavily dependent on disease prevalence. In high-risk settings, a negative test is statistically much more likely to be a false negative than a true negative.
4
Evaluate the clinical consequence of the resident's pathway.
A negative D-dimer in this high-risk patient has an unacceptably high false-omission rate. Therefore, the diagnosis cannot be safely excluded, making the test useless.
When a test cannot alter management regardless of the result, it should not be ordered. The patient should proceed directly to definitive imaging (CTPA).

Key Concept

The predictive value of a test depends heavily on pretest probability (disease prevalence). In patients with a high pretest probability, a negative result from a sensitive screening test yields a low Negative Predictive Value (NPV), meaning it cannot safely rule out the disease.
Rate this question

Topics

Diagnostic Testing Performance

More questions from this topic